Literature DB >> 6236577

Generalised allergic reactions to aminophylline.

P J Thompson, W R Gibb, P Cole, K M Citron.   

Abstract

Details of three patients who developed allergic responses to aminophylline are presented, together with data on such reactions compiled from reports submitted to the Committee on Safety of Medicines. Two of the patients developed generalised rashes within one day of starting treatment with oral aminophylline. Other symptoms included malaise and confusion. A third patient had severe generalised symptoms and a high fever, which was reproduced on challenge testing. Forty five of 147 reactions to aminophylline reported to the Committee on Safety of Medicines referred to dermatological or allergic reactions and in two instances exfoliative dermatitis was described. In contrast, only seven of 61 reported reactions to theophylline described skin or allergic responses and in none of these was dermatitis or a specified rash mentioned. The available evidence suggests that ethylenediamine rather than the xanthine component of aminophylline may be the principal cause of the reactions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236577      PMCID: PMC1020513          DOI: 10.1136/thx.39.8.600

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

1.  Urticaria following intravenous aminophylline.

Authors:  B H Booth; W P Coleman; D Q Mitchell
Journal:  Ann Allergy       Date:  1979-11

2.  Allergic eczematous sensitivity to aminophylline; report of a case.

Authors:  R L BAER; H J COHEN; A H NEIDORFF
Journal:  AMA Arch Derm       Date:  1959-06

3.  Ethylenediamine-induced exfoliative erythroderma.

Authors:  J E Bernstein; A L Lorincz
Journal:  Arch Dermatol       Date:  1979-03

4.  Allergic contact dermatitis.

Authors:  E Epstein; H I Maibach
Journal:  Arch Dermatol       Date:  1968-11

5.  Letter: Allergy to ethylenediamine.

Authors:  K E Eriksen
Journal:  Arch Dermatol       Date:  1975-06

6.  Two cases of allergy to aminophylline.

Authors:  Z Mohsenifar; S Lehrman; S A Carson; D Tashkin
Journal:  Ann Allergy       Date:  1982-11

7.  The pharmacokinetics of lysine theophylline, a new soluble theophylline, in human volunteers.

Authors:  A Johnston; M E Aldhous; A Hedges; K Weerasuriya; A Freedman; P Turner
Journal:  Postgrad Med J       Date:  1983-02       Impact factor: 2.401

8.  Allergy to aminophylline: lack of predictability by skin testing.

Authors:  W A Kradjan; S Lakshminarayan
Journal:  Am J Hosp Pharm       Date:  1981-07

9.  Ethylenediamine-induced asthma.

Authors:  S Lam; M Chan-Yeung
Journal:  Am Rev Respir Dis       Date:  1980-01

10.  Hypersensitivity reactions to ethylenediamine in aminophylline.

Authors:  J A Elias; A I Levinson
Journal:  Am Rev Respir Dis       Date:  1981-05
View more
  3 in total

1.  Cutaneous drug eruption from aminophylline use during dipyridamole nuclear stress testing.

Authors:  Wanzhen Zeng; Steven Glassman; Mary Dalipaj; Terrence Ruddy
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

2.  Theophylline pharmacokinetics after intravenous infusion with ethylenediamine or sodium glycinate.

Authors:  J Caldwell; A H Staib; I A Cotgreave; M Siebert-Weigel
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

3.  Theophylline and ethylenediamine pharmacokinetics following administration of aminophylline to septic patients with multiorgan failure.

Authors:  P Toft; L Heslet; M Hansen; N A Klitgaard
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.